Literature DB >> 3335789

Identification of collagen fibrils in scleroderma skin.

J S Perlish1, G Lemlich, R Fleischmajer.   

Abstract

Skin from early and late stages of scleroderma has been shown to contain large amounts of thin (30-40 nm diameter) collagen fibrils that may be present in bundles or intermingled with large diameter fibrils (90-120 nm). The nature of these fibrils is unknown. Skin biopsies were obtained from involved areas of nine patients with progressive systemic sclerosis (PSS), one case of generalized morphea, one case of morphea, and six normal controls. Intact skin was analyzed by immunoelectron microscopy (IEM), while extracts were subjected to sodium dodecyl polyacrylamide gel electrophoresis (SDS-PAGE), Western immunoblotting, radioimmunoassay (RIA), and enzyme-linked immunosorbent assay (ELISA). Fine fibrils 20-40 nm in diameter in the mid to lower dermis of scleroderma skin were labeled with antibodies directed against the aminopropeptide (AP) of type III procollagen. Antibodies directed against the AP of type I procollagen labelled fine fibrils in the lower dermis. Larger fibrils (80-120 nm) did not label. pN alpha 1 (III) was found to be present in both normal and scleroderma skin. Extracts of scleroderma skin contained 2.5 times the amount of pN (III) collagen and 3.0 times the amount of fibronectin as did extracts of normal skin. The data indicate that the increase in thin fibrils in scleroderma skin is most likely due to an increase in type III collagen, which retains the AP at its surface.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3335789     DOI: 10.1111/1523-1747.ep12462561

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  16 in total

1.  Identification of regulators of the myofibroblast phenotype of primary dermal fibroblasts from early diffuse systemic sclerosis patients.

Authors:  Loubna Chadli; Britt Sotthewes; Kejie Li; Stefan N Andersen; Ellen Cahir-McFarland; Marc Cheung; Patrick Cullen; Annemarie Dorjée; Jeska K de Vries-Bouwstra; Tom W J Huizinga; David F Fischer; Jeroen DeGroot; Joanne L Viney; Timothy S Zheng; Jamil Aarbiou; Agnes Gardet
Journal:  Sci Rep       Date:  2019-03-14       Impact factor: 4.379

2.  Altered procollagen mRNA expression during the progression of avian scleroderma.

Authors:  M J Ausserlechner; R Sgonc; H Dietrich; G Wick
Journal:  Mol Med       Date:  1997-10       Impact factor: 6.354

Review 3.  Double heterozygous mice for Klf5 and Fli1 genes: a new animal model of systemic sclerosis recapitulating its three cardinal pathological features.

Authors:  Yoshihide Asano
Journal:  Med Mol Morphol       Date:  2015-05-19       Impact factor: 2.309

4.  Nrf2 exerts cell-autonomous antifibrotic effects: compromised function in systemic sclerosis and therapeutic rescue with a novel heterocyclic chalcone derivative.

Authors:  Jun Wei; Hongyan Zhu; Gabriel Lord; Mitra Bhattachayya; Brielle M Jones; Graham Allaway; Shyam S Biswal; Benjamin Korman; Roberta G Marangoni; Warren G Tourtellotte; John Varga
Journal:  Transl Res       Date:  2016-12-09       Impact factor: 7.012

Review 5.  Molecular and cellular basis of scleroderma.

Authors:  Beate Eckes; Pia Moinzadeh; Gerhard Sengle; Nico Hunzelmann; Thomas Krieg
Journal:  J Mol Med (Berl)       Date:  2014-07-18       Impact factor: 4.599

6.  Elevated expression of type VII collagen in the skin of patients with systemic sclerosis. Regulation by transforming growth factor-beta.

Authors:  L Rudnicka; J Varga; A M Christiano; R V Iozzo; S A Jimenez; J Uitto
Journal:  J Clin Invest       Date:  1994-04       Impact factor: 14.808

7.  Differential regulation of transcription and transcript stability of pro-alpha 1(I) collagen and fibronectin in activated fibroblasts derived from patients with systemic scleroderma.

Authors:  B Eckes; C Mauch; G Hüppe; T Krieg
Journal:  Biochem J       Date:  1996-04-15       Impact factor: 3.857

8.  Collagen XII and XIV, new partners of cartilage oligomeric matrix protein in the skin extracellular matrix suprastructure.

Authors:  Pallavi Agarwal; Daniela Zwolanek; Douglas R Keene; Jan-Niklas Schulz; Katrin Blumbach; Dick Heinegård; Frank Zaucke; Mats Paulsson; Thomas Krieg; Manuel Koch; Beate Eckes
Journal:  J Biol Chem       Date:  2012-05-09       Impact factor: 5.157

9.  Protective effects of halophyte complex extract against UVB-induced damage in human keratinocytes and the skin of hairless mice.

Authors:  Jae Young Shin; Ji Hyeon Park; Denis Nchang Che; Hyun Ju Kang; Byoung Ok Cho; Yi Teak Lim; Seon Il Jang
Journal:  Exp Ther Med       Date:  2021-04-25       Impact factor: 2.447

10.  Histomorphometric analysis of cutaneous remodeling in the early stage of the scleroderma model.

Authors:  Cristiane Carla de Oliveira; Ana Paula Pereira Velosa; Edwin Roger Parra; Vera Luiza Capelozzi; Walcy Rosolia Teodoro; Natalino Hajime Yoshinari
Journal:  Clinics (Sao Paulo)       Date:  2009       Impact factor: 2.365

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.